The Effect of Health Expenditures on Human Capital: A Panel Data Analysis of OECD Economies

Yıl 2023, Sayı: 112, 103 - 134, 05.12.2023

Aslı Zakire Yüksel Haluk Şengün

https://doi.org/10.36484/liberal.1168935

Öz

Health is one of the basic components of Human Capital according to The World Bank Human Capital Index, along with education. Health status is the physical and mental performance of individuals in sustaining their daily normal activities. The health expenditures are one of the most prominent determinants of health status. This paper estimates the effects of health expenditures on health status as an input and a proxy of human capital for OECD Economies through a Health Production Function based on The Grossman Model. Life Expectancy at Birth (LEBIRTH), Infant Mortality Rates (IMR), Potential Years of Life Lost (PYLL) are used as measures of health status. The Ratio of Total Health Expenditures to GDP, percapita Total Health Expenditures, percapita Public Health Expenditures, percapita Private Health Expenditures, percapita Pharmaceutical Health Expenditures are specified as independent variables. Fixed Effects and Random Effects models are used due to the results of Haussman Test. Results suggest that health expenditures have significant effects on health status and so on human capital and economic growth.

Anahtar Kelimeler

Healthcare Expenditure, Health Status, Human Capital, Growth

Sağlık Harcamalarının Beşeri Sermayeye Etkisi: OECD Ekonomilerinin Panel Veri Analizi

Öz

Dünya Bankası Beşeri Sermaye Endeksi’ne göre beşeri sermaye, “eğitim ve sağlık” bileşenlerinden oluşmaktadır. Sağlık statüsü, bir toplumda bireylerin normal gündelik aktivitelerini sürdürebilmesini sağlayabilecek fiziksel ve mental performansıdır. Sağlık statüsünün en önemli belirleyicilerinden biri ise sağlık harcamalarıdır. Bu çalışmada; Grossman Modeli’ne dayanan bir Sağlık Üretim Fonksiyonu aracılığıyla, 32 OECD ekonomisinin 2000-2018 dönemi dengesiz panel veri seti ve 24 OECD ekonomisinin 2000-2015 dönemi dengeli panel veri seti kullanılarak; sağlık harcamalarının beşeri sermayenin bir girdisi ve aynı zamanda proxy’si olan sağlık statüsüne etkisi tahmin edilmiştir. Çalışmada bağımlı değişken olarak kullanılan sağlık statüsü ölçütleri şunlardır: Doğuştan Yaşam Beklentisi (LEBIRTH), Bir Yaş Altı Bebek Ölüm Oranları (IMR), Kaybedilen Potansiyel Yaşam Yılları’dır (PYLL). Bağımsız değişkenler ise Toplam Sağlık Harcamalarının GSYİH’ya Oranı, Kişibaşı Kamusal Sağlık Harcamaları, Kişibaşı Özel Sağlık Harcamaları ve Kişibaşı İlaç Harcamalarıdır. Analizlerde Hausman Testi sonuçlarına göre Sabit Etkiler ve Rassal Etkiler modelleri kullanılmıştır. Bulgular; sağlık harcamalarının sağlık statüsünü, dolayısıyla da beşeri sermaye ve ekonomik büyümeyi anlamlı ve beklenen yönde etkilediğini göstermektedir.

Anahtar Kelimeler

sağlık harcamaları, sağlık statüsü, beşeri sermaye, büyüme

Destekleyen Kurum

Yok

Kaynakça

• Abel-Smith, Brian&World Health Organization. (‎1967)‎. An International Study of Health Expenditure and Its Relevance For Health Planning. World Health Organization.Public Health Papers, no. 32. https://apps.who.int/iris/handle/10665/62927 (04.01.2022)
• Ades, F.; Senterre, C.; de Azambuja, E.; Sullivan, R.; Popescu, R.; Parent, F.; Piccart, M. (2013) “Discrepancies in Cancer Incidence And Mortality and Its Relationship To Health Expenditure in The 27 European Union Member States”, Annals of Oncology, 24(11), 2897–2902.
• Akkoyunlu, S., Lichtenberg, F. R., Siliverstovs, B. & Zweifel, P. (2010). “Spurious Correlation in Estimation of The Health Production Function: A Note”, Economics Bulletin, 30(3), 2505-2514.
• Alvarez, I., Javier B., & Jose L. Z. (2017). “A Panel Data Toolbox for MATLAB”, Journal of Statistical Software, January, 76(6). (https://www.jstatsoft.org/article/view/V076i06)
• Asiskovitch, S. (2010). “Gender and Health Outcomes: The Impact Of Healthcare Systems and Their Financing on Life Expectancies Of Women And Men”, Social Science and Medicine, 70(6), 886-895.
• Babazono, A. & Hillman, A. L. (1994). “A Comparison of International Health Outcomes and Health Care Spending”, International Journal of Technology Assessment in Health Care, 10(3), 376-381.
• Baldacci, E., Guin-Siu, M. T. & De Mello, L. (2003). “More on The Effectiveness of Public Spending on Health Care And Education: A Covariance Structure Model”, Journal of International Development, 15(6), 709-725.
• Baltagi, Badi H. (2001). Econometric Analysis of Panel Data. 4th Edition. John Wiley and Sons.
• Baltagi, B. H., Moscone, F. & Tosetti, E. (2012). “Medical Technology and The Production of Health Care”, Empirical Economics, 42(2), 395-411.
• Becker, G. S. (1965). “A Theory of The Allocation of Time”, The Economic Journal, 75(299), 493–517.;
• Becker, G.S. (1967). “Human Capital and The Personal Distribution Of Income”, University of Michigan Press, Ann Arbor. Reprinted in G.S. Becker (1993) Human Capital: a Theoretical and Empirical Analysis, with Special Reference To Education. 3rd ed. University of Chicago Press.
• Becker, Gary S. (2007). “Health as Human Capital: Synthesis and Extensions”, Oxford Economic Papers 59, 379–410.
• Ben-Porath, Y. (1967). “The Production of Human Capital and The Life-Cycle of Earnings”, Journal of Political Economy, 75(4), 352-365.
• Berger, M. C. & Messer, J. (2002). “Public Financing of Health Expenditures, Insurance, and Health Outcomes”, Applied Economics, 34(17), 2105-2113.
• Bloom, David and David Canning. (2003). Health as Human Capital and its Impact on Economic Performance. The Geneva Papers on Risk and Insurance. Issues and Practice, 28(2), 304-315. https://www.jstor.org/stable/41952692#metadata_info_tab_contents (03. 08.2021)
• Breusch, T. & Pagan, A. (1980). “The LM Test and its Application to Model Specification in Econometrics”, Review of Economic Studies, 47, 239–254.
• Budhdeo, S., Watkins J., Atun, R., Callum, W., Zeltner T., & Maruthappu M., (2015). “Changes İn Government Spending on Healthcare And Population Mortality in the European Union. 1995-2010: A Cross-Sectional Ecological Study”, Journal of Royal Society of Medicine, 108(12), 490-8.
• Caliskan, Z. (2009). “The Relationship Between Pharmaceutical Expenditure And Life Expectancy: Evidence From 21 OECD Countries”, Applied Economics Letters, 16(16), 1651-1655.
• Cameron, A.C. & Trivedi P.K. (2010) Microeconometrics Using Stata, Stata Press Publications.
• Chang, A.Y., Hammitt, J. K., S.C. Resch Et L., & Robinson, A. (2017). ““The Economics in Global Health 2035: A Sensitiviy Analysis of the Value of a Life Year Estimates”,TSE Working Paper, No: 17-756, Janvier. (https://www.tse-fr.eu/fr/publications/economics-global-health-2035-sensitivity-analysis-value-life-year-estimates).
• Cline, Liu, L., Schondelmeyer, R. R., & Schommer, J. C. (2008). “Pharmaceutical Expenditures as a Correlate of Population Health in Industrialized Nations”, Annals of Pharmacotherapy, 42(3), 368-374.
• Cochrane, A. L., A. S. St. Leger & Moore. F. (1978). “Health Service ‘‘Input’’ And Mortality ‘‘Output’’ in Developed Countries”, Journal of Epidemiology and Community Health, 32, 200–205.
• Conley, D. & Springer, K. W. (2001). “Welfare State and Infant Mortality”, American Journal of Sociology, 107(3), 768-807.
• Crémieux, P. Y., Meilleur, M. C., Ouellette, P., Petit, P., Zelder, M., & Potvin, K. (1999). “Health Care Spending as Determinants of Health Outcomes”, Health Economics, 8(7), 627-639.
• Crémieux, P. Y., Meilleur, M. C., Ouellette, P., Petit, P., Zelder, M., & Potvin, K. (2005). “Public And Private Pharmaceutical Spending as Determinants of Health Outcomes in Canada”, Health Economics, 14(2): 107-116.
• Day, K. & Tousignant, J. (2005). “Health Spending, Health Outcomes, and Per Capita Income in Canada: A Dynamic Analysis”, Working Paper 2005-07 (Department of Finance, Canada), June.
• Doğan, İ., Tülüce, N. & Doğan, A. (2014). “Dynamics of Health Expenditures in OECD Countries: Panel ARDL Approach”, Theoretical Economics Letters, 4, 649-655.
• Drastichová, Magdaléna & Filzmoser, Peter (2020). “The relationship between health outcomes and health expenditure in europe by using compositional data analysis”, Problemy Ekorozwoju, 15(2), 99—110.
• Eberhardt, Markus (2011). “Panel Time-Series Modeling: New Tools for Analyzing XT Data”, Stata Users Group Meeting Cass Business School, London 16th September. https://www.stata.com/meeting/uk11/abstracts/uk11_eberhardt.pdf
• Eggleston, K., Yu-Chu S., Joseph L., Christopher H. S., & Chan J. (2006) “Hospital Ownership and Quality Of Care: What Explains The Different Results?”, NBER Working Paper Series, No: 12241
• Eissa, Noura, (2020) “Pandemic Preparedness and Public Health Expenditure”, Economies, 8, 60, 1-17.
• Elola, J., Daponte, A., & Navarro, V. (1995). “Health İndicators and The Organization of Health Care Systems in Western Europe”, American Journal of Public Health, 85(10), 1397-1401.
• Farag, M. (2009). “Health Financing and Health Outcomes in The Eastern Mediterranean Region”, Working Paper. https://www.belfercenter.org/sites/default/files/legacy/files/farag_-_working_paper_-_fınal.pdf.
• Frech H. E. & Miller R. D. (2004). “The Effects of Pharmaceutical Consumption and Obesity on The Quality Of Life in The OECD Countries”, Pharmacoeconomics, 22(Supplement), 25-36.
• Frech, H. E. & Miller, R. D., Jr. (1996). “The Productivity of Health Care and Pharmaceuticals: An International Comparison”, UCLA Research Program in Pharmaceutical Economics and Policy. Https://Escholarship.Org/Uc/İtem/0d90459k
• Frech, H. E. & Miller, R. D., Jr. (1999). “The Productivity of Healthcare And Pharmaceuticals: An International Comparison”, American Enterprise Institute, .Washington, DC:
• Gangadharan L. & Valenzuela M. R. (2001). “Interrelationships Between Income, Health and The Environment: Extending The Environmental Kuznets Curve Hypothesis”, Ecological Economics, 36(3), 365–547.
• GRETL. (2020). Regression Analysis in Practice with GRETL. https://Peterfoldvari.Com/Regression%20analysis%20with%20GRETL.Pdf (18/12/2020)
• Grootendorst, P., Emmanuelle, P. & Minsup S. (2009). “Life-Expectancy Gains From Pharmaceutical Drugs: A Critical Appraisal of The Literatüre”, Expert Review of Pharmacoeconomics and Outcomes Research, 9(4), 353-64.
• Grossman, M. (1972a). “On The Concept Of Health Capital and The Demand For Health”, Journal of Political Economy, 80, 223-255.
• Grossman, M. (1972b). “The Demand For Health: A Theoretical and Empirical Investigation”, National Bureau of Economic Research, Number: 119 in Occasional Paper, New York.
• Guindon, G. & Paul Contoyannis (2012) “A Second Look At Pharmaceutical Spending As Determinants of Health Outcomes in Canada”, Health Economics, 21(12), 1477-1495.
• Halicioglu, F. (2011). “Modeling Life Expectancy in Turkey”, Economic Modelling, 28(5), 2075-2082.
• Hall, S. G., Swamy, P. A. V. B., & Tavlas, G. S. (2012). “Generalized Cointegration: A New Concept With An Application to Health Expenditure and Health Outcomes”, Empirical Economics, 42(2), 603-618.
• Hausman, J. A. (1978). “Specification Tests in Econometrics”, Econometrica, Vol. 46, No. 6 (Nov.), 1251-1271. https://www.researchgate.net/publication/264382660_hausman_1978
• Hermanowski, T., Victor B., Staszewska-Bystrova, A., Szafraniec-Buryło, S. I., Rabczenko, D., Kolasa, K., Orlewska, E. (2015). “Analysis Of Trends in Life Expectancies and Per capita Gross Domestic Product As Well As Pharmaceutical And Non-Pharmaceutical Healthcare Expenditures”, Acta Poloniae Pharmaceutica, 72(5),1045-50.
• Heuvel, W.J. & Olaroiu, M. (2017). “How Important Are Health Care Expenditures for Life Expectancy? A Comparative, European Analysis”, Journal of The American Medical Directors Association, 18(3), 276.E9-276.E12.
• Hitiris, T. & Posnett, J. (1992). “The Determinants and Effects of Health Expenditure in Developed Countries”, Journal of Health Economics, 11, 173-181.
• Inthakesone, Bounmy (2018) The Impact of Health Care Expenditure On Elder Mortality Rate in Japan, https://www.researchgate.net/publication/328538040_title_the_ımpact_of_health_care_expenditure_on_elder_mortality_rate_in_japan. (05/09/2021)
• Jee, M. & Or, Z. (1999). “Health Outcomes in OECD Countries: A Framework of Health Indicators for Outcome Oriented Policymaking”, OECD Labour Market and Social Policy Occasional Papers, No. 36.
• Joumard, I., André, C., Nicq, C., & Chatal, O. (2008). “Health Status Determinants: Lifestyle, Environment, Health Care Resources and Efficiency”, OECD Economics Department Working Paper, No: 627.
• Khan, J.R.; Awan, N.; Islam, M.M.; Muurlink. (2020) O. “Healthcare Capacity, Health Expenditure, and Civil Society as Predictors of COVID-19 Case Fatalities: A Global Analysis”, Front. Public Health, 8, 347.
• Lichtenberg, Frank R. (2002) “Sources of U.S. Longevity Increase: 1960-1997”, NBER Workıng Paper, 8755, January, https://www.nber.org/papers/w8755
• Lichtenberg, Frank R. (2004). “Sources of US Longevity Increase: 1960–2001”, The Quarterly Review of Economics and Finance, 44(3), 369-389.
• Linden, M. & Ray, D. (2017). “Life Expectancy Effects Of Public And Private Health Expenditures in OECD Countries 1970-2012: Panel Time Series Approach”, Economic Analysis and Policy, 56, p. 101-113.
• Lorenzoni, Luca; Alberto Marino, David Morgan, and Chris James (2019). “Health Spending Projections to 2030: New Results Based On A Revised OECD Methodology”, OECD Health Working Paper No. 110.
• Martin, S., Rice, N. & Smith, P. C. (2008). “Does Health Care Spending Improve Health Outcomes? Evidence From English Programme Budgeting Data”, Journal of Health Economics, 27(4), 826-842.
• Maruthappu, M, Ka Ying Bonnie Ng, Williams, C.,Atun, R., Agrawal, P., & Zeltner, T. (2015a). “The Association Between Government Healthcare Spending And Maternal Mortality in The European Union, 1981-2010: A Retrospective Study”, An International Journal of Obstetrics and Gynaecology, 122(9), 1216-1224.
• Maruthappu, M., Painter, A., Watkins, J., Callum, W., Raghib A., Zeltner, T., Faiz, O., & Hemant, S. (2014). “Unemployment, Public-Sector Healthcare Spending And Stomach Cancer Mortality in The European Union. 1981-2009”, European Journal of Gastroenterology Hepatol, 26(11), 1222-1227.
• Maruthappu, M., Watkins, J., Waqar, M., Callum, W., Raghib, A., Atun, R., Faiz, O., & Zeltner, T. (2015d). “Unemployment, Public-Sector Health-Care Spending And Breast Cancer Mortality in The European Union: 1990-2009”, European Journal of Public Health, 25(2), 330-335.
• Maruthappu, M., Watson, R., Watkins, J., Callum, W., Zeltner, T. , Faiz, O., Raghib, A., & Atun, R. (2016). “Unemployment, Public-Sector Healthcare Expenditure And Colorectal Cancer Mortality in The European Union: 1990-2009”, International Journal of Public Health, 61(1), 119-130.
• Miller, R. D. & Frech T. (2002). “The Productivity of Healthcare and Pharmaceuticals: Quality of Life Cause”, UCSB Departmental Working Papers, No: 12-02, 1-42.
• Miller, Richard D., Jr., & Frech, H. E. (2000). “Is There A Link Between Pharmaceutical Consumption And Improved Health in OECD Countries?”, Pharmacoeconomics, 18, 33–45.
• Miller, Richard D., Jr., & Frech, H. E. (2004). “The Effects Of Pharmaceutical Consumption And Obesity on The Quality of Life in The Organization of Economic Cooperation and Development (OECD) countries”, Pharmacoeconomics, 18, 25–36.
• Mohan, Ramesh & Mirmirani, Sam. (2008). “An Assessment of OECD Health Care System Using Panel Data Analysis”, Southwest Business & Economics Journal,16, 21-35.
• Myumng, Hun (2011). “Practical Guides To Panel Data Modeling: A Step By Step”, Analysis Using Stata. University of Japan. Nixon, J. & Ulmann, P. (2006). “The Relationship Between Health Care Expenditure And Health Outcomes” The European Journal of Health Economics, 7(1), 7-18.
• OECD (2021) Health Statistics 2021. https://www.oecd-ilibrary.org/sites/ae3016b9-en/1/3/7/1/index.html
• Onofrei, Mihaela; Vatamanu, Anca-Florentina, Vintilă Georgeta, Cigu Elena (2021). “Government Health Expenditure and Public Health Outcomes: A Comparative Study among EU Developing Countries”, International Journal of Environmental Research and Public Health, 18, 1-13.
• Or, Zeynep (2000a). “Determinants Of Health Outcomes in Industrialised Countries: A Pooled, Cross-Country, Time Series Analysis”, OECD Economic Studies, No. 30, 2000/I.
• Or, Zeynep (2000b). “Exploring The Effects Of Health Care on Mortality Across OECD Countries”, OECD Labour Market and Social Policy, Occasional Paper, No. 46.
• Or, Zeynep, J. Wang & D. Jamison (2005). “International Differences in The Impact Of Doctors On Health: A Multilevel Analysis Of OECD Countries”, Journal of Health Economics, 24, 531-560.
• Peltzman, Sam. (1987). “Regulation and Health: The Case of Mandatory Prescriptions and An Extension”, Managerial and Decision Economics, 8(1), 41–6.
• Pritchett, L. & Summers, L.H. (1996). “Wealthier is Healthier”, Journal of Human Resources, No.31 (4), 841-868.
• Ravallion, Martin, & Shaohua Chen (1997). “What Can New Survey Data Tell Us About Recent Changes in Distribution And Poverty?”, World Bank Economic Review, 11(2), 357–82.
• Reyna, Oscar Torres. (2007). Panel Data Analysis Fixed and Random Effects Using Stata. https://www.princeton.edu/~otorres/panel101.pdf (18(10/2021)
• Ruiz-Pérez, I., Bermúdez-Tamayo, C., Rodríguez-Barranco, M. (2017). “Socio-Economic Factors Linked With Mental Health During The Recession: A Multilevel Analysis”, International Journal of Equity Health, 16(1), 45.
• Santerre, R. E., Grubaugh, S. G., & Stollar, A. J. (1991). “Government İntervention in Health Care Markets And Health Care Outcomes: Some international Evidence”, Cato Journal, 11(1), 1-12.
• Shaw, J. W., Horrace W. C., & Vogel R. J. (2002). “The Productivity of Pharmaceuticals in Improving Health: An Analysis Of The OECD Health Data”, WUSTL Economics Working Paper, Archive, HEW 0206001, 1–42.
• Shaw, J.W., Horrace, W. C. and Vogel, R. (2005). “The Determinants of Life Expectancy: An Analysis of OECD Health Data”, Southern Economic Journal, 71(4), 768-783.
• Squire, Lyn (1993). “Fighting Poverty”, American Economic Review: Papers and Proceedings, 83(2), Pp. 377–82.
• The Lancet Commissions (2013) Global Health 2035: A World Converging Within A Generation. http://globalhealth2035.org/sites/default/files/report/global-health-2035.pdf. (18/01/2022)
• Thornton, J. (2002). “Estimating Health Production Function for The Us: Some New Evidence”, Applied Economics, 34, 59-62. UN (2020). Human Development Index. http://hdr.undp.org/en/content/human-development-index-hdi. (20/11/2021)
• WHO (2001) “Commission on Macroeconomics and Health-2001”, Macroeconomics and Health: Investing in Health For Economic Development, Geneva, 20 December.
• Wolfe, Barbara L., (1986). “Health Status and Medical Expenditures: Is There a Link?”, Social Science and Medicine, 22(10), 993-999.
• Wolfe, Barbara and Gabay, Mary, (1987). “Health Status And Medical Expenditures: More Evidence of A Link”, Social Science and Medicine, 25(8), 883-888.
• Woodward A. and I. Kawachi (2000). “Why Reduce Health Inequalities?”, Journal of Epidemiology and Community Health, 54, 923-929.
• Wooldridge, J. M. (2002). Econometric Analysis of Cross Section And Panel Data. MIT Press.
• WorldBank (2022) About The Human Capital Project. https://www.worldbank.org/en/publication/human-capital/brief/about-hcp (01/12/2022)